141 related articles for article (PubMed ID: 27459024)
1. Recombinant human granulocyte macrophage colony stimulating factor (hGM-CSF): Possibility of nanoparticle-mediated delivery in cancer immunotherapy.
Vanitha S; Chaubey N; Ghosh SS; Sanpui P
Bioengineered; 2017 Mar; 8(2):120-123. PubMed ID: 27459024
[TBL] [Abstract][Full Text] [Related]
2. Formulation and In Vitro Characterization of PLGA/PLGA-PEG Nanoparticles Loaded with Murine Granulocyte-Macrophage Colony-Stimulating Factor.
Mihalik NE; Wen S; Driesschaert B; Eubank TD
AAPS PharmSciTech; 2021 Jun; 22(5):191. PubMed ID: 34169366
[TBL] [Abstract][Full Text] [Related]
3. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
Hofer M; Vacek A; Weiterová L
Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
5. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
Broxmeyer HE; Benninger L; Patel SR; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1994 Jan; 22(1):100-2. PubMed ID: 7506671
[TBL] [Abstract][Full Text] [Related]
6. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
[TBL] [Abstract][Full Text] [Related]
8. Low concentrations of recombinant granulocyte macrophage-colony stimulating factor derived from Chinese hamster ovary cells augments long-term bioactivity with delayed clearance in vitro.
Hashimoto A; Tanaka T; Itoh Y; Yamagata A; Kitamura N; Tazawa R; Nakagaki K; Nakata K
Cytokine; 2014 Aug; 68(2):118-26. PubMed ID: 24813650
[TBL] [Abstract][Full Text] [Related]
9. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor.
Krosl G; Korbelik M; Krosl J; Dougherty GJ
Cancer Res; 1996 Jul; 56(14):3281-6. PubMed ID: 8764122
[TBL] [Abstract][Full Text] [Related]
12. Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.
Schwenter F; Zarei S; Luy P; Padrun V; Bouche N; Lee JS; Mulligan RC; Morel P; Mach N
Cancer Gene Ther; 2011 Aug; 18(8):553-62. PubMed ID: 21566667
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in murine peritoneal exudate macrophages by both GM-CSF and IL-3.
Fan K; Ruan Q; Sensenbrenner L; Chen BD
J Immunol; 1992 Jul; 149(1):96-102. PubMed ID: 1535090
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the growth-inhibitory and apoptosis-inducing activities of a triterpene saponin, securioside B against BAC1.2F5 macrophages.
Yui S; Kudo T; Hodono K; Mimaki Y; Kuroda M; Sashida Y; Yamazaki M
Mediators Inflamm; 2003 Jun; 12(3):157-66. PubMed ID: 12857599
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha.
Zhu JQ; Wu J; Zhu DX; Scharfman A; Lamblin G; Han KK
Cell Mol Biol; 1991; 37(4):413-9. PubMed ID: 1934015
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines.
Helftenbein G; Krusekopf K; Just U; Cross M; Ostertag W; Niemann H; Tamura T
Oncogene; 1996 Feb; 12(4):931-5. PubMed ID: 8632916
[TBL] [Abstract][Full Text] [Related]
17. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells.
Obermueller E; Vosseler S; Fusenig NE; Mueller MM
Cancer Res; 2004 Nov; 64(21):7801-12. PubMed ID: 15520186
[TBL] [Abstract][Full Text] [Related]
18. Influence of varying doses of granulocyte-macrophage colony-stimulating factor on pharmacokinetics and antibody-dependent cellular cytotoxicity.
Liljefors M; Nilsson B; Mellstedt H; Frödin JE
Cancer Immunol Immunother; 2008 Mar; 57(3):379-88. PubMed ID: 17676322
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
20. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
